Ho:YAG Laser, Thulium Laser Fiber Both Effective for Stone Management

WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- For ureteroscopic stone management, there is no significant difference between pulse-modulated holmium:yttrium-aluminum-garnet (Ho:YAG) laser and thulium laser fiber, according to a study published in the February issue of The Journal of Urology.
Christopher R. Haas, M.D., from the University of Wisconsin in Madison, and colleagues compared the clinical effectiveness of pulse-modulated Ho:YAG laser and thulium laser fiber for ureteroscopic stone management. A total of 108 patients were randomly assigned (52 to Ho:YAG and 56 to thulium laser fiber) and had primary end point data available.
The researchers observed no significant difference between the modalities in ureteroscopy time (mean 21.4 and 19.9 minutes for Ho:YAG and thulium laser fiber, respectively) or in analyses within subgroups by stone size, median Hounsfield units, or stone location. No significant differences were seen between the lasers in the stone-free rate or complication rates.
"This randomized clinical trial suggests no significant clinical advantage of one laser technology over the other," the authors write. "As both laser technologies are safe and highly effective, surgeon and institutional preference is the best approach when selecting one or the other."
Editorial Comment 1 (subscription or payment may be required)
Editorial Comment 2 (subscription or payment may be required)
Editorial Comment 3 (subscription or payment may be required)
Related Posts
Los antibióticos de las cesáreas no se vinculan con el asma en la niñez
VIERNES, 20 de mayo de 2022 (HealthDay News) -- Administrar antibióticos a una...
Aumentan las visitas de niños a urgencias por crisis de salud mental con el inicio del período escolar
LUNES, 25 de septiembre de 2023 (HealthDay News) -- Aunque el inicio del año...
Kim Kardashian Just Got a Whole-Body MRI Scan. Should You?
MONDAY, Sept. 18, 2023 (HealthDay News) -- Whole-body MRI scans are the latest...
Unos fármacos para el VIH ayudan a reducir el riesgo de infección casi a cero, según un estudio
LUNES, 24 de julio de 2023 (HealthDay News) -- Las personas que toman terapia...
